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1104Objectives: Few studies have described the survival of low-birth-weight infants weighing less than 1.5 kg at
operation for a cardiac malformation. Our goal was to determine if body weight at surgery affects survival.
Methods: This was a retrospective cohort study using outcome data from the Pediatric Cardiac Care Consortium
between 1982 and 2006.
Results:We reviewed the outcomes of 450 consecutive infants with a cardiac anomaly and a birth weight of less
than 1.5 kg, and weight of less than 2.5 kg at surgery. Of these, 179 patients had undergone surgery with a weight
of less than 1.5 kg and 271 patients weighed 1.5 to 2.5 kg at surgery. The 30-day survival ratewas 83% for cohort
1 and 86% for cohort 2. For patients not requiring cardiopulmonary bypass, the 30-day survival rate was 86%
for cohort 1 and 92% for cohort 2. For patients requiring cardiopulmonary bypass, the 30-day survival rate was
69% for cohort 1 and 73% for cohort 2. No notable improvement in the outcomes occurred over time.
Conclusions: For low-birth-weight infants (weight<1.5 kg) undergoing a major cardiac procedure, the survival
of infants weighing less than 1.5 kg at surgery is comparable to that of infants who weighed 1.5 to 2.5 kg. We
conclude that, in our series, weight was not an independent risk factor for mortality, and, therefore, operative
delay because of patient weight might be unwarranted. (J Thorac Cardiovasc Surg 2010;140:1104-9)Earn CME credits at
http://cme.ctsnetjournals.org
During the past 5 decades, the care of children with cardiac
lesions has progressed to the successful use of a wider range
of cardiac operations. As the techniques have improved,
a trend has occurred to operate on ever younger and smaller
infants, with improving success.1 One persisting barrier re-
lates to low-birth-weight infants (<1500 g) with an urgent
need of operative repair or palliation.
Many studies have reviewed the safety and benefits of
major cardiac surgery in infants weighing less than 2.5
kg.2-16 Very few of the infants included in these studies
have weighed less than 1.5 kg at surgery, which raises the
question, ‘‘How small is too small?’’ The decision to
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The Journal of Thoracic and Cardiovascular Surretrospective multi-institutional study focused on infants
with a birth weight of 1.5 kg or less to determine whether
deferring cardiac surgery until the infant weighs more im-
proves the chances of survival.
MATERIALS AND METHODS
A retrospective review of the data from the Pediatric Cardiac Care Con-
sortium (PCCC), a multi-institutional database, from 1982 to 2006, re-
vealed 105,609 infants and children with a cardiac anomaly who had
undergone a cardiac operation from 58 participating centers. The institu-
tional review board of the University of Minnesota approved the use of
the database for research purposes. Because of the nature of the study,
the patient or family consent requirement was waived. Infants who had un-
dergone patent ductus arteriosus ligation as the primary operation were ex-
cluded from our analysis.
We reviewed the surgical outcomes of all low-birth-weight infants in the
PCCC registry with a birth weight less than 1.5 kg. Previous reports7,16
have suggested that infants with a weight of less than 2.5 kg at surgery
have a particularly high risk of surgical mortality. We hypothesized that
within this group, infants with a lower weight at surgery would be at the
greatest risk, and we divided them into 2 subgroups: those weighing less
than 1.5 kg at surgery, and those weighing 1.5 and 2.5 kg at surgery. The
low-birth-weight infants who had undergone surgery weighing more
were most likely to be hemodynamically stable and growing and therefore
were not included in the present analysis. We reviewed the cardiac diagno-
sis, operation types, and survival outcomes. The patient survival rates were
evaluated for both 30-day and in-hospital survival (survival until discharge,
if>30 days). The effects of the year of surgery and weight class on survival
were investigated using contingency table methods and Fisher’s exact tests.
All data analysis was performed using the Statistical Analysis Systems,
version 9.2 (SAS Institute, Inc, Chicago, Ill).
RESULTS
Using these entry criteria, we identified 450 infants from
47 participating centers with a birth weight of 320 to 1500 g.gery c November 2010
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
PCCC ¼ Pediatric Cardiac Care Consortium
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of less than 1500 g and 271 at a weight of 1.5 to 2.5 kg. The
infants studied had a variety of cardiac conditions com-
monly requiring surgery in the neonatal period (Table 1).
The types of operations performed were similar between
the 2 groups (Table 1). The age at surgery ranged from
0 to 139 days (mean 21 days, median 14 days, mode 13
days) for those weighing less than 1500 g. The age at sur-
gery ranged from 5 to 153 days (mean 58 days, median
53 days, mode 49 days) for the group weighing 1.5 to 2.5
kg. The risk assessment for congenital heart surgery score
(RACHS) was recorded for each group. The range was 1
to 6, with a mean of 2.65 for the group weighing less than
1.5 kg and a mean of 2.56 for the heavier group (Figure 1).
A total of 179 infants underwent cardiac surgery at
a weight of less than 1.5 kg. The 30-day survival rate for
that group was 83% (n ¼ 148). The in-hospital survival
rate was 73% (n ¼ 130). A total of 271 infants underwent
cardiac surgery at a weight of 1.5 to 2.5 kg. The 30-day sur-
vival rate was 86% (n ¼ 233). The in hospital survival rate
was 77% (Figure 2). A statistical analysis of survival as
a function of weight class was performed using Fisher’s
exact c2 test and yielded a P value of .352 for the 30-day
survival and P ¼ .263 for in-hospital survival. The survival
rates were not different between the infants undergoing
surgery weighing less than 1.5 kg and those undergoing
surgery weighing 1.5 to 2.5 kg.
We analyzed the operative outcomes of these 2 groups by
5-year periods (Figure 3). Surgery was performed on more
low-weight infants each year during the study; however,
more hospitals were also participating in the PCCC with
time. The statistical analyses of survival as a function of
period, both ignoring the weight class and considering the
weight class, were performed using Fisher’s exact tests.
All P values were> .4. Thus, no statistically significant
improvement in outcome occurred over time.
Finally, survival after various types of operations was
assessed. Infants in whom more than 1 procedure was
performed at the same operation were classified according
to the procedure with the greatest risk assessment for
congenital heart surgery score. The patients were divided
according to 3 types of procedures: (1) not requiring cardio-
pulmonary bypass (CPB); (2) operations needing CPB; and
(3) pacemaker implantation. The 30-day survival rates for
each category are listed in Table 1 and shown in Figure 4,
stratified by weight group. Because at least 5 comparisons
were made within each of the operative categories, theThe Journal of Thoracic and CarFisher’s exact test P values were compared to a Bonfer-
roni-adjusted a value of 0.01.
Of the operations performed without CPB, the only sub-
group that showed a trend toward a statistically significant
improvement in the group weighing more for 30-day
survival was the coarctation of the aorta repair group
(P¼ .03). When evaluating all those undergoing operations
not needing CPB, no improvement was seen in the survival
of the higher weight group versus the lower weight group
(P ¼ .14) (Table 1 and Figure 4).
For operations in which CPBwas used, the survival in the
heavier group of neonates was no different from those in the
lower weight group (P ¼ .67).
Finally, 11 infants weighing less than 1.5 kg and 6 infants
weighing 1.5 to 2.5 kg at surgery underwent pacemaker
implantation for heart block. In the group weighing less
than 1.5 kg, 7 infants survived to 30 days (64%), and in
the heavier group, 5 survived to 30 days (83%). No statis-
tically significant difference was seen in survival for the
heavier group compared with the lower weight group
(P ¼ .60).
No deaths occurred in the less than 1.5-kg group (unless
coupled with another procedure) for the following
procedures: vascular ring surgery (n ¼ 8), cardiac tumor
surgery (n ¼ 1), truncus arteriosus repair (n ¼ 1), ventricu-
lar septal defect repair (n ¼ 2), complete atrioventricular
canal repair (n ¼ 1), and ligation of an anomalous coronary
artery (n ¼ 1).
DISCUSSION
It is difficult to balance the appropriate care of a prema-
ture or low-birth-weight infant with a major cardiac lesion.
Infants with a cardiac anomaly are at an increased risk of
birth weight.17 Furthermore, very-low-birth-weight neo-
nates with a cardiac anomaly have increased overall mortal-
ity compared with heavier and more mature infants.13 Such
neonates often have extracardiac malformations4 and other
issues related to prematurity.18 When combined with an un-
repaired cardiac malformation, severe and prolonged mor-
bidity can result.4,19 The timing of the operation is
important, because undue delay can worsen the neonate’s
condition without the benefit of improved cardiovascular
status.2,19 Chang and colleagues2 showed that delayed inter-
vention increased morbidity and mortality, without addi-
tional benefit. Reddy and colleagues5 found that delayed
intervention was associated with increased complications,
such as ventilator dependency, poor weight gain, sepsis,
necrotizing enterocolitis, chronic pulmonary disease, and
renal failure, especially in very-low-weight infants. They
concluded that corrective (instead of palliative) surgery
should be considered, even in the very-low-weight groups,
when technically feasible.4-6,14
In 2000, Reddy and Hanley4 reported that a delay in
repair results in ‘‘extraordinary morbidity’’ and that morediovascular Surgery c Volume 140, Number 5 1105
TABLE 1. Patient characteristics and 30-day survival stratified by weight group and operation type
Variable Surgical weight<1.5 kg Surgical weight 1.5–2.5 kg P value
Total infants 179 271
Birth weight (kg) 1.04 (0.46-1.48) 1.18 (0.32-1.50) .197*
Surgical age (d) 21 (0-139) 58 (5-153) .0001*
RACHS-1 score 2.65 (1-6) 2.56 (1-6) .717*
Operations with CPB
Type Survived/total (%) Survived/total (%)
VSD/AV canal repair 10/11 (91%) 26/29 (90%) 1
ASD repair 2/2 (100%) 7/7 (100%) 1
RVOT repair 5/8 (63%) 6/13 (46%) .66
HLHS repair 1/7 (14%) 6/9 (67%) .06
TAPVR repair 1/2 (50%) 7/9 (78%) .49
Other 8/9 (89%) 11/19 (58%) .20
All operations with CPB 27/39 (69%) 63/86 (73%) .67
Operations without CPB
Type
Coarctation/arch repair 64/72(89%) 69/70 (99%) .03
Shunts 21/27(78%) 67/75 (89%) .19
Pulmonary artery banding 21/22(95%) 25/29 (86%) .37
Vascular ring repair 8/8 (100%) 4/4 (100%) 1
Pacemaker placement 7/11 (64%) 5/6 (83%) .60
RV perforation repair 0/0 0/1 NA
All operations without CPB 121/140 (86%) 170/185 (92%) .14
All operations 148/179 (83%) 233/271 (86%) .35
P values from Fisher’s exact tests. Because of multiple comparisons, none reached statistical significance. RVOT group included transannular patch repair (4 and 9), infundibular
resection (1 and 2), and pulmonary valvectomy (3 and 2 patients, respectively). RACHS-1, risk adjustment for congenital heart surgery; CPB, cardiopulmonary bypass; VSD,
ventricular septal defect; AV canal, atrioventricular canal defect; ASD, atrial septal defect; RVOT, right ventricular outflow tract;HLHS, hypoplastic left heart syndrome; TAPVR,
total anomalous pulmonary venous return; RV, right ventricular. *Performed using JMP software (SAS Institute).
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Dfavorable results were achieved with early repair in very-
low-weight infants (< 1500 g). None of their patients had
intracranial bleeding, even when CPB was required. They
had success with, and suggested early and complete repair
of, simple and even highly complex cardiac anomalies in
this group of small infants. They also found that the
complication rates and need for reintervention was similarFIGURE 1. Risk assessment for congenital heart surgery scores had sim-
ilar distribution in both groups, with mean score of 2.65 for less than 1.5-kg
group and 2.55 for 1.5- to 2.5-kg group.
1106 The Journal of Thoracic and Cardiovascular Surto those of full-term neonates. This challenging subgroup
of neonates might be best treated at centers with expertise
in caring for very-low-weight neonates, especially if symp-
tomatic or ventilator dependent.4,5FIGURE 2. Rates of 30-day and in-hospital survival by weight group, with
179 infants in the less than 1.5-kg group and 271 infants in the 1.5- to 2.5-kg
group. Error bars indicate 95% confidence intervals for survival propor-
tions. Fisher’s exact tests gave no evidence of differences in 30-day survival
(P ¼ .3522) or in-hospital survival (P ¼ .2630) between the weight groups.
gery c November 2010
FIGURE 3. Rates of 30-day survival by era for the 2 weight groups.
Fisher’s exact tests gave no evidence of a time trend in 30-day survival
(P>.5). Increasing number of patients undergoing surgery over time might
have resulted from increased number of programs participating in Pediatric
Cardiac Care Consortium (PCCC) database over time.
Shepard et al Congenital Heart Disease
C
H
DOne study noted that very-low-birth-weight neonates, in
general, have a high incidence of neurologic handicaps. The
immature blood-brain barrier has increased permeability,
a greater potential for brain edema, and a greater incidence
of spontaneous intracerebral/intraventricular bleeding. The
investigators suggested that CPB might increase this risk
but described only 2 such cases.15
A recent study by Curzon and colleagues16 compared the
outcomes of infants weighing 1.5 to 2.5 kg with those of pa-
tients weighing 2.5 to 4 kg at surgery, without regard to the
birth weight. They found that certain subgroups in the lower
weight population had elevated mortality rates compared
with their heavier counterparts, including coarctation ofFIGURE 4. Rates of 30-day survival by operative category for the 2
weight groups. (Operations involving a pacemaker were separated from
the ‘‘no CPB’’ group for Figure 4.) Error bars indicate 95% confidence in-
tervals for survival proportions. Fisher’s exact tests gave no evidence of dif-
ference in 30-day survival between the 2 weight groups for any of the 3
operative categories (P>.14).
The Journal of Thoracic and Carthe aorta, total anomalous pulmonary venous connection,
d-transposition of the great arteries, pulmonary atresia
with a ventricular septal defect, and single ventricle lesions.
The overall survival rate of the less than 2.5-kg group was
84%.16 Our population was not large enough to statistically
evaluate such subdivisions.
The perioperative risk factors must also be considered.
Several risk-stratifying categories exist (eg, risk assessment
for congenital heart surgery score and Aristotle20,21) to help
clinicians assess the postoperative prognosis. Preoperative
acidosis and the need for inotropic support are significant
risk factors for a poor outcome.14 A prolonged crossclamp
time, extracorporeal membrane oxygenation, palliative (in-
stead of corrective) surgery, prolonged intensive care unit
stay, and prolonged ventilator dependency have each been
associated with worse outcomes.14
Our study had some important limitations related to the
nature of the PCCC database. For example, the registry
does not include information about the perioperative status
(ie, gestational age, complications, central nervous system
events) or the clinical indications for proceeding with or de-
laying surgery. Some patients who survived an initial oper-
ation did not survive a subsequent one. The available data
did not allow quantification of long-term survival. A limited
number of high complexity cases were included in the CPB
group, with only a few in each specific operation. Therefore,
the conclusions of our study do not necessarily extrapolate
to this unique population. Finally, another important limita-
tion was that infants with cardiac defects who do not un-
dergo an intervention are not reported to the database.
For the 25 years for which we have data, an increasing
number of low-birth-weight infants underwent surgery at
these centers. For low-birth-weight infants undergoing sur-
gery for cardiac lesions, we found no supportive evidence
that surgery at a weight of 1.5 to 2.5 kg improved the sur-
vival rate compared with surgery at a weight of less than
1.5 kg. In our series, the survival rate for low-birth-weight
infants remained relatively constant from 1982 to 2006
for either weight class.
The 1.5- to 2.5-kg group underwent surgery an average of
37 days later than the less than 1.5-kg group. The mortality
rates were not significantly different, except for a borderline
significant difference for infants undergoing coarctation re-
pair (P ¼ .03). When those undergoing CPB were subdi-
vided by procedure, few patients were in each of the high
complexity groups. Of these patients, those with hypoplas-
tic left heart syndrome and a greater weight had borderline
significantly improved survival (P ¼ .06); however, larger
numbers are required to confirm this finding. In the other
groups, no evidence was found of a benefit from delaying
surgery for infants with a birth weight less than 1.5. Further-
more, delaying surgery causes the neonates to be exposed to
prolonged intensive care (including mechanical ventilation,
inotropic support, prostaglandin exposure, the potential fordiovascular Surgery c Volume 140, Number 5 1107
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Dinfection, and so forth) and its complications while having
poor weight gain. On the other hand, if the infant could
avoid these exposures, the data suggest that waiting might
not be detrimental. As expected, CPB resulted in greater
risk than procedures that did not require its use; however,
the outcomes were similar for both weight groups. Our
findings approximate the success rates found in previous
studies.13,14 Previous studies2-15 have reported the single-
center experience from highly specialized centers. These
reports typically included only limited numbers of patients
in the very-low-weight group, because this is such a unique
population. In contrast, our study has provided the accumu-
lated experience of many small and mid-size centers across
the United States and Canada. Thus, the information from
our study is unique and helpful as more cardiac centers con-
sider early cardiac repair for low-weight neonates. The
morbidity and long-term outcomes should be studied fur-
ther as more infants in this population undergo early correc-
tive surgery.
Cardiologists, surgeons, and neonatologists must collab-
orate to prepare the patient for surgery and should not use
weight as the sole factor for operative timing, because these
infants will have poor weight gain until the correction is
performed.18 The techniques and skill levels are continu-
ously improving, making it ever safer to correct complex
cardiac malformations. Knowing the likelihood of success
can help the decision of when to operate and affords fami-
lies realistic expectations of the final outcome.References
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Dr Peter J. Gruber (Philadelphia, Pa). Dr Shepard, thank you
for your very clear presentation on this difficult set of patients and,
especially, your willingness to review over 105,000 charts.
We are frequently faced with decisions as to when to operate on
small infants, and, when we need to do so, we must decide on the
best operative strategy, whether palliation or complete repair, as
well as the timing. Certainly, in the past 10 years there has not
been much hesitancy on the part of most surgeons to perform com-
plex operations, regardless of weight, for purely technical reasons.
Indeed, as you point out in your presentation, there has been
substantial data reporting the safety and benefits of expeditious
surgery, even in small infants. However, there is also, as you point
out, considerable evidence that complications increase with lower
body weight. The most prominent among these is the comprehen-
sive analysis of the Society of Thoracic Surgeons database re-
ported 2 years ago by Dr Curzon that compared the mortality in
patients weighing less than and more than 2.5 kg for several oper-
ative procedures. The results of that study comprehensively docu-
mented an increase in mortality for the group weighing less than
2.5 kg for many operative groups.
You asked a different question using a different approach and
divided that highest risk group into 2 categories, those less than
1.5 kg and those greater than 1.5 kg but less than 2.5 kg, and to
my knowledge, the precise analysis of this group has not previ-
ously been reported.
To me, the results were a little surprising. One might have ex-
pected that those less than 1.5 kg would have had worse outcomes
than those greater than 1.5 kg, and, in general, you showed that
they did not.
So I have 3 questions for you.
The first is on the elaboration of the Pediatric Cardiac Care Con-
sortium (PCCC) and its relationship to the Society of Thoracic
Surgeons database and whether any of these patients overlap—gery c November 2010
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center every 2 years, which is a highly heterogeneous group.
Dr Shepard. First, regarding the PCCC, this is a database that
was started in 1982 at the University of Minnesota that through the
years has grown. Programs have added themselves and other taken
themselves out of this database throughout those years. There is
overlap with the Society of Thoracic Surgeons database (some
centers participate in both databases), and so some of these pa-
tients might have also been in that database. As to the second
part of the question, we considered the participation over time
for these centers. It was not as heterogeneous as 1 patient every
other year per institution. There were institutions that during the
25-year period entered as few as 1 patient, and I believe the
most patients from any given institution was about 11. This is
such a small specialized population that it is very hard to find large
numbers for this group.
Dr Gruber. The second question, I would be curious to know
whether you noted historical differences in patients operated on
during almost a quarter of a century. There has been considerable
refinement in the techniques both intra- and perioperatively. Did
you see any improvement over that time?
Dr Shepard. We know from previous studies that in heavier
weight infants and children, there was an improvement in surgical
outcomes over time. In our study, we evaluated by 5-year periods
and foundno improvement over time for this low-weight population,
looking at all institutions. Theremight have beenmore of an effect if
we had isolated just the larger institutions and looked at their im-
provement curves over time; however, thatwas not part of this study.
Dr Gruber.My last question is regarding gestational age. Were
these patients small for gestational age and/or premature? Cer-
tainly, there is a close relationship between prematurity and small
for gestational age, but they might underscore different mecha-
nisms of risk. Can you comment?
Dr Shepard. That is a very important point, and one that I
would very much like to look into further. That information was
not included uniformly in our database so that would need to be
a case-by-case review. However, I believe that would add more
light to this subject, as would other questions of preoperative vari-
ables that added in and led to the timing of these procedures that
were unclear from the data that we have in our database.
Dr Harald L. Lindberg (Oslo, Norway). I have no disclosures.
Congratulations on a very nice paper.
But I wonder, were there any deaths in the group that was wait-
ing for surgery? Do you have any information on that at all? Be-
cause that would be a really major influence on your results if
you have a certain percentage of death or morbidity from waiting
for surgery, that would advocate earlier repair.
Dr Shepard. This database records the cardiac operations
and catheterizations so those patients who do not make it to sur-
gery or cardiac catheterization will not be in the database. ThatThe Journal of Thoracic and Carwould be a wonderful addition to this study if I could find that
information.
Dr Lindberg. A second question, do you have any information
if there were more patients on the ventilator or inotropic support in
the group that waited for surgery or those who were primarily op-
erated?
Dr Shepard. These preoperative co-factors would help us to
understand why some patients were operated on early versus late
and might offer further insight into the question of surgical timing
in these high-risk infants. The PCCC does not record that informa-
tion, so it would have to come from a chart-by-chart review, with
charts from 47 different centers.
Dr Ali Dodge-Khatami (Hamburg, Germany). Among these
patients there were a lot of shunts, coarctations, and also pulmo-
nary artery bandings. For those of us in the room who are perhaps
less bold to undertake such surgery in these very small infants, I
did not get what percentage of these cases were done electively
or what percentage were done because you had no other choice,
with your back to the wall, let us say, extreme cyanosis or, on
the other hand, cardiac failure?
The corollary to that question would be, if you do have the
choice of waiting a bit longer to perhaps let the infants grow
a bit more—of course, 38 more days in the hospital is a long
time with cost issues, et cetera—but would it be justified to
wait in some of these patients if you can? Do you have that
percentage?
Dr Shepard. I do not have that percentage or that information.
We did not have, again, the reason for timing of the intervention of
the operation. That is something that would be very beneficial to
add on as a follow-up to this study to determine why the timing
was such and whether there would be an advantage to waiting or
a reason for going early.
Dr Glen Van Arsdell (Toronto, Ontario, Canada). That was
a nice presentation and you have done a nice job explaining the
limitations of the paper because you did not have the ability to
enroll based on an intention to treat.
One of the questions I have is how did you choose theweight for
creating the 2 groups? Some studies have taken the approach of
saying let us look at risk on an incremental weight basis. Did
you analyze weight as a continuous variable as opposed to a cate-
gorical variable?
Dr Charles Shepard.We did not analyze weight as a continu-
ous variable. We chose 1.5 kg as the marker that had been set in the
past as a very high-risk category. Then, in an attempt to have a com-
parison group, we chose those that were at a heavier operative
weight but similar birth weights and similar risk assessment for
congenital heart surgery scores.
Dr Van Arsdell. It might be an interesting analysis to do, be-
cause a number of studies have shown that weight, as an incremen-
tal component, is a risk of poor outcomes.diovascular Surgery c Volume 140, Number 5 1109
